QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
ASX:DXS

DEXUS (DXS) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
5.01 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.23%
Price Target
N/A

DXS stock logo

About DEXUS (ASX:DXS) Stock

Dexus (ASX: DXS) is one of Australia's leading fully integrated real asset groups, managing a high-quality Australasian real estate and infrastructure portfolio valued at $62.3 billion (pro forma post completion of the Collimate Capital acquisition). We believe that the strength and quality of our relationships will always be central to our success and are deeply committed to working with our customers to provide spaces that engage and inspire. We directly own $17.8 billion of office and industrial assets and investments. We manage a further $44.5 billion of investments in our funds management business (pro forma post completion of the Collimate Capital acquisition) which provides third party capital with exposure to quality sector specific and diversified real asset products. The funds within this business have a strong track record of delivering outperformance and benefit from Dexus's capabilities. The group's $15.8 billion development pipeline provides the opportunity to grow both portfolios and enhance future returns. We consider sustainability (ESG) to be an integral part of our business with the objectives of Leading Cities, Future Enabled Customers, Strong Communities, Thriving People and an Enriched Environment supporting our overarching goal of Sustained Value. Dexus is listed on the Australian Securities Exchange and is supported by more than 31,000 investors from 23 countries. With over 35 years of expertise in property investment, funds management, asset management and development, we have a proven track record in capital and risk management and delivering superior risk-adjusted returns for investors.


DXS Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Dexus Stapled Securities (DXS.AX)
Dexus FY Net Loss A$752.7 Million
Dat Xanh Real Estate Services JSC (DXS)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Dexus Finance Pty Limited: Changes to Leadership team
Dat Xanh Real Estate Service JSC
Dexus Finance Pty Limited: Appendix 3Y - Elana Rubin
Dexus Finance Pty Limited: September 2022 quarter update
Dexus Finance Pty Limited: 2022 AGM Chair and CEO Address
See More Headlines
Receive DXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DEXUS and its competitors with MarketBeat's FREE daily newsletter.

DXS Company Calendar

Ex-Dividend for 8/29 Dividend
6/28/2023
Dividend Payable
8/29/2023
Today
10/02/2023

Industry, Sector and Symbol

Industry
REIT—Office
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,079
Year Founded
N/A

Profitability

Net Income
$-752,700,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$861.20 million
Book Value
A$11.43 per share

Miscellaneous

Outstanding Shares
1,080,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
0.65
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Darren Joseph Steinberg BEc
    F.A.C.I.D., FAICD, FAPI, FRICS, CEO & Exec. Director of DEXUS Funds Management Limited
  • Ms. Keir L. Barnes B.Com.
    M.B.A., Chief Financial Officer of Dexus Funds Management Limited
  • Mr. Ross G. Du Vernet M.B.A.
    Chief Investment Officer of Dexus Funds Management Limited
  • Ms. Melanie Bourke B.Com.
    M.B.A., Chief Operating Officer of Dexus Funds Management Limited
  • Ms. Rowena Causley
    Head of Investor Relations
  • Mr. Brett D. Cameron B.A.
    GAICD, L.L.B., Gen. Counsel & Company Sec. of Dexus Funds Management Limited
  • Louise Murray
    Sr. Mang. of Corp. Affairs & Communications
  • Mr. Paul Oates
    Group Gen. Mang. of Devel.
  • Mr. Richard Garing
    Regional Gen. Mang. of Office & Industrial
  • Mr. Michael Cummings
    Co-Head of Infrastructure of Dexus Funds Management Limited













DXS Stock - Frequently Asked Questions

How often does DEXUS pay dividends? What is the dividend yield for DEXUS?

DEXUS announced a Final dividend on Monday, June 26th. Shareholders of record on Tuesday, August 29th will be paid a dividend of 0.236 per share on Tuesday, August 29th. This represents a dividend yield of 3.1%. The ex-dividend date of this dividend is Wednesday, June 28th.
Read our dividend analysis for DXS
.

Is DEXUS a good dividend stock?

DEXUS (ASX:DXS) pays an annual dividend of A$0.47 per share and currently has a dividend yield of 6.23%. DXS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for DXS.

What other stocks do shareholders of DEXUS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DEXUS investors own include Metrics Master Income Trust (MXT), First Quantum Minerals (FM), EastGroup Properties (EGP), The Carlyle Group (CG) and Abacus Property Group (ABP).

What is DEXUS's stock symbol?

DEXUS trades on the ASX under the ticker symbol "DXS."

How much money does DEXUS make?

DEXUS (ASX:DXS) has a market capitalization of $0.00 and generates $861.20 million in revenue each year. The company earns $-752,700,000.00 in net income (profit) each year or A($0.64) on an earnings per share basis.

How many employees does DEXUS have?

The company employs 1,079 workers across the globe.

How can I contact DEXUS?

DEXUS's mailing address is Australia Square, L 25 264-278 George St, SYDNEY, NSW 2000, Australia. The official website for the company is www.dexus.com. The company can be reached via phone at +61-2-90171100.

This page (ASX:DXS) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -